FDA Green Lights Ketamine for Treatment of ALS
Business, Policy
"This designation not only expedites our regulatory, clinical, and product development plans but also validates our belief in the potential of ketamine," says PharmaTher CEO Fabio Chianelli.
This was a great and interesting article to read. I have really enjoyed all of this very cool and fun information. Thanks